| TGF-β-mediated silencing of genomic organizer SATB1 promotes Tfh cell differentiation and formation of intra-tumoral tertiary lymphoid structures RA Chaurio, CM Anadon, TL Costich, KK Payne, S Biswas, CM Harro, ... Immunity 55 (1), 115-128. e9, 2022 | 97 | 2022 |
| Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T cells CM Anadon, X Yu, K Hänggi, S Biswas, RA Chaurio, A Martin, KK Payne, ... Cancer Cell 40 (5), 545-557. e13, 2022 | 88 | 2022 |
| IgA-Dominated Humoral Immune Responses Govern Patients' Outcome in Endometrial Cancer G Mandal, S Biswas, CM Anadon, X Yu, CD Gatenbee, S Prabhakaran, ... Cancer Research 82 (5), 859-871, 2022 | 39 | 2022 |
| IgA-dominated humoral immune responses govern patients' outcome in endometrial cancer G Mandal, S Biswas, CM Anadon, X Yu, CD Gatenbee, S Prabhakaran, ... Cancer Research, 2021 | 39 | 2021 |
| Olfactory receptor OR2H1 is an effective target for CAR T cells in human epithelial tumors AL Martin, CM Anadon, S Biswas, JA Mine, KF Handley, KK Payne, ... Molecular cancer therapeutics 21 (7), 1184-1194, 2022 | 21 | 2022 |
| Methyltransferase inhibitors restore SATB1 protective activity against cutaneous T cell lymphoma in mice CM Harro, J Perez-Sanz, TL Costich, KK Payne, CM Anadon, RA Chaurio, ... The Journal of clinical investigation 131 (3), 2021 | 10 | 2021 |
| Actionable spontaneous antibody responses antagonize malignant progression in ovarian carcinoma KF Handley, S Mehta, AL Martin, S Biswas, K Maharaj, MZ Nagy, JA Mine, ... Gynecologic Oncology 173, 114-121, 2023 | 4 | 2023 |
| Sézary syndrome originates from heavily mutated hematopoietic progenitors CM Harro, KB Sprenger, RA Chaurio, JJ Powers, P Innamarato, ... Blood Advances, 2023 | 2 | 2023 |
| Olfactory receptor OR5V1 is an effective target for CAR T cells in ovarian cancer (207) A Martin, CMA Galindo, S Biswas, J Mine, G Mandal, P Innamarato, ... Gynecologic Oncology 166, S116, 2022 | 1 | 2022 |
| CAR T cells targeting Olfactory Receptor OR2H1 are an effective immunotherapeutic option in human epithelial tumors S BISWAS, A Martin, CMA Galindo, J Mine, KK Payne, G Mandal, ... The Journal of Immunology 208 (1_Supplement), 117.16-117.16, 2022 | 1 | 2022 |
| Utilization of immortalized B cells to identify SDCBP as a novel therapeutic target in ovarian carcinoma. K Handley, S Mehta, A Martin, S Biswas, KK Maharaj, JA Mine, C Cortina, ... Journal of Clinical Oncology 40 (16_suppl), e14507-e14507, 2022 | | 2022 |
| Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T-cells CMA Galindo, X Yu, S Biswas, R Chaurio, G Mandal, A Martin, KK Payne, ... The Journal of Immunology 208 (1_Supplement), 63.04-63.04, 2022 | | 2022 |
| Spontaneous class-switched antibody responses at endometrial cancer tumor bed drives superior patients’ outcome G MANDAL, S Biswas, CM Anadon, X Yu, CD Gatenbee, S Prabhakaran, ... The Journal of Immunology 208 (1_Supplement), 177.01-177.01, 2022 | | 2022 |
| SATB1 Expression Governs Follicular Helper T-cell-Triggered Tertiary Lymphoid Structure Assembly RA Chaurio, CM Anadon, TL Costich, KK Payne, S Biswas, CM Harro, ... | | |
